1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo-

Request For Quotation
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Products Intro: Product Name:G9a-IN-2
CAS:2648853-26-1
Purity:98% Package:1g
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:G9a-IN-2
CAS:2648853-26-1
Package:50mg;10mg
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Basic information
Product Name:1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo-
Synonyms:1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo-;G9a-IN-2
CAS:2648853-26-1
MF:C30H42N4O4
MW:522.68
EINECS:
Product Categories:
Mol File:2648853-26-1.mol
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Structure
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Chemical Properties
Boiling point 706.5±60.0 °C(predicted)
density 1.167±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka13.17±0.70(predicted)
Safety Information
MSDS Information
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Usage And Synthesis
UsesG9a-IN-2 (Compound 7i) is an inhibitor for histone methyltransferases G9a with IC50 of 0.024 μM. G9a-IN-2 reduces H3K9me2 levels and induces the mRNA expression of γ-globin mRNA. G9a-IN-2 shows the potential in ameliorating sickle cell disease (SCD)[1].
References[1] Nishigaya Y, et al., Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatment. Bioorg Med Chem Lett. 2024 Jun 22;110:129856. DOI:10.1016/j.bmcl.2024.129856
1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo- Preparation Products And Raw materials
Tag:1H-Indole-2-carboxamide, 4,5,6,7-tetrahydro-3,6,6-trimethyl-N-[(1S)-1-[[[4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]carbonyl]pentyl]-4-oxo-(2648853-26-1) Related Product Information
EPZ015666 GSK-3326595 UNC-0642 UNC0638 DS-3201 MRTX-1719